Bysanti is based on iloperidone, an active metabolite of a compound that forms the core of Fanapt, another drug by Vanda Pharmaceuticals.

Key opportunities in the bio-pharmaceutical logistics market include the expansion in personalized medicine distribution, ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Key opportunities in the healthcare logistics market include the expansion of pharmaceutical distribution networks, rising ...

Novel intravenous anti-inflammatory candidate advances to Phase I evaluation to assess safety, tolerability, and ...

TAIZHOU CITY, ZHEJIANG PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- The global pharmaceutical chemicals ...

Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months. | Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months with two FDA approvals and ...

Unnatural Products, a biotech company founded by UC Santa Cruz alumni Cameron Pye (Ph.D. ’17, chemistry & biochemistry) and ...

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and ...

Teijin Pharma has signed a joint research agreement with Aska Pharmaceutical to develop small-molecule drug candidates for ...

Bioengineered E. coli produced 40 times more orsellinic acid, a precursor to anti-inflammatory compounds, compared to previous microbial models. This platform serves as a basis for the production of ...